• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-07-01

  This study reveals that Gasdermin C (GSDMC) promotes stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC) through a mechanism independent of pyroptosis. By identifying ADAM17-mediated nuclear translocation of GSDMC fragments as a key driver, these findings open new strategies for targeting PDAC aggressiveness and improving immunotherapy response.

• Losmapimod (GW856553X): Advanced p38 MAPK Modulation for Tra

  2026-06-30

  This article bridges cutting-edge mechanistic insight with practical strategy for translational researchers investigating inflammation and vascular dysfunction. Leveraging new findings on dual-action kinase inhibition and p38α activation loop dynamics, we reframe the value of Losmapimod (GW856553X) as not only a potent p38 MAPK inhibitor but a precision tool for workflow innovation in preclinical and clinical settings. The discussion integrates recent structural biology advances, APExBIO product intelligence, and validated research protocols—providing an actionable roadmap for maximizing the therapeutic and experimental impact of Losmapimod.

• Nelfinavir Mesylate: Applied HIV-1 Protease Inhibition & Fer

  2026-06-30

  Nelfinavir Mesylate stands apart as both a gold-standard HIV-1 protease inhibitor and a precision tool for dissecting protein homeostasis and ferroptosis in advanced cell-based assays. This guide translates the latest mechanistic insights into actionable protocols, troubleshooting strategies, and workflow enhancements for researchers navigating antiviral and cell death pathways.

• N3-kethoxal: High-Fidelity Probe for RNA & DNA Accessibility

  2026-06-29

  N3-kethoxal, also known as 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one, enables precise, covalent labeling of unpaired guanine in RNA and single-stranded DNA. Its azide group supports robust click chemistry, facilitating high-resolution structural probing and genomic mapping for nucleic acid research.

• Acetylcysteine in Research: Optimizing Oxidative Stress Work

  2026-06-29

  Acetylcysteine (N-acetyl-L-cysteine) is redefining experimental workflows in oxidative stress pathway modulation, hepatic protection research, and advanced disease modeling. This article decodes real-world protocols, highlights APExBIO’s high-purity offering, and delivers actionable troubleshooting tips for robust, reproducible results.

• BMS-777607: Mechanistic Precision in MET Pathway Inhibition

  2026-06-28

  Explore how BMS-777607, a selective c-Met inhibitor, advances cancer and stem cell research by targeting the MET signaling pathway. This article delivers a mechanistic deep dive and practical guidance for experimental design, providing unique insights beyond standard protocols.

• Biotin-XX Tyramide Reagent: High-Fidelity Surface Signal Amp

  2026-06-27

  Biotin-XX Tyramide Reagent is a membrane-impermeant, HRP-activated probe for ultrasensitive cell surface protein labeling. Its long polyamide linker enables selective extracellular labeling, critical for tyramide signal amplification workflows in neuroscience and histology. This article details its mechanism, evidence, and protocol integration for advanced spatial proteomics.

• Phenacetin in Advanced Pharmacokinetic Studies: Protocols &

  2026-06-26

  Leverage high-purity Phenacetin (N-(4-ethoxyphenyl)acetamide) from APExBIO to streamline drug metabolism and pharmacokinetic workflows in hiPSC-derived organoids. Discover actionable protocols, troubleshooting insights, and the impact of allosteric PDK4 inhibitors on metabolic research.

• HBsAg Hijacks TBK1 to Suppress Interferon and Induce Autopha

  2026-06-26

  This study reveals how hepatitis B surface antigen (HBsAg) directly manipulates TANK-binding kinase 1 (TBK1) to suppress type I interferon production and induce incomplete autophagy. These findings clarify a distinct viral immune evasion mechanism, highlighting new targets for chronic HBV intervention.

• Oscillatory mTORC1 Activity Regulates Cell Cycle and Autopha

  2026-06-25

  Joshi et al. demonstrate that mTORC1 activity oscillates with the cell cycle, peaking in S/G2 and reaching its lowest at mitosis and G1. This dynamic regulation governs mitotic entry and influences autophagy induction, offering new mechanistic insights into cell proliferation and metabolic control.

• Amyloid Beta-Peptide (1-40): Rethinking Translational Strate

  2026-06-25

  This thought-leadership article explores Amyloid Beta-Peptide (1-40) (human) as more than a model for fibril aggregation: it is positioned as a dynamic tool for dissecting the molecular and cellular underpinnings of Alzheimer’s disease, with unique relevance to imaging, microglial signaling, and translational assay design. Integrating fresh mechanistic insights and referencing emerging ratiometric imaging approaches, the article provides strategic guidance for translational researchers seeking to elevate both experimental rigor and clinical applicability in Alzheimer’s disease research.

• SMPD4-Driven Sphingolipid Metabolism in Brain and Cilia Deve

  2026-06-24

  This study establishes SMPD4 as a critical regulator of sphingolipid metabolism, linking its function to the development of the brain and primary cilia. By combining mouse models and human iPSC systems, the authors reveal that SMPD4-dependent ceramide production is vital for neural progenitor survival and cilia integrity, with implications for understanding microcephaly and cerebellar hypoplasia.

• PDK4-IN-1 Hydrochloride: Precision Pyruvate Dehydrogenase Ki

  2026-06-23

  PDK4-IN-1 hydrochloride empowers researchers to achieve nanomolar-selective inhibition of pyruvate dehydrogenase kinase 4, unlocking rigorous modulation of mitochondrial metabolism in metabolic, cardiac, and cancer research. This guide delivers actionable workflows, troubleshooting, and unique advantages for deploying this APExBIO tool in advanced cellular and in vivo studies.

• Syringin in Oncology: Mechanistic Insights and Research Util

  2026-06-23

  Explore Syringin as a bioactive natural product with unique mechanistic action in renal cell carcinoma research. This article delivers advanced scientific analysis and practical assay guidance, setting it apart from protocol-driven content.

• Elobixibat Hydrate: Translational Leverage in Bile Acid Modu

  2026-06-22

  This thought-leadership article explores how Elobixibat hydrate is reshaping translational research in gastrointestinal and metabolic disorders. By dissecting the mechanistic foundations of ileal bile acid transporter inhibition, reviewing experimental and clinical evidence, and providing actionable guidance for research teams, we position Elobixibat hydrate as the bridge between molecular insight and therapeutic innovation. The article also contextualizes this compound within a landscape of evolving clinical need and highlights future directions for translational science.

454 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page